Lupus Research Alliance News
Introducing Gary Koretzky, MD, PhD, New Scientific Advisory Board Co-Chair

May 10, 2019 We are so fortunate to welcome Dr. Gary Koretzky as the new Co-chair partnering with Dr. Mary Crow in leading the Lupus Research Alliance (LRA) Scientific Advisory Board.  As Professor of Medicine at Weill Cornell Medicine and Vice Provost for Academic Integration of Cornell University, Dr. Koretzky creates and implements initiatives that […] READ MORE

How Lupus Research Alliance Grants Boosted Benlysta

In 1999, lupus research needed a shot in the arm. The Food and Drug Administration hadn’t approved a new drug for treating the disease in more than 40 years. And the death rate from lupus, which fell earlier in the century, had been rising for the previous two decades. Now, 20 years later, the outlook […] READ MORE

The Numbers Add Up to 20 Years of Extraordinary Progress

May 1, 2019 The Lupus Research Alliance is honored to serve the lupus community as the global leader in lupus research, both in the resources we deploy and the results we deliver.  Collectively we have invested more than $200 million in over 500 grants selected by a multi-level peer review process led by world-class luminaries […] READ MORE

Gene Changes Key to Successful Pregnancy in Lupus

April 29, 2019 Pregnant women with lupus are more likely to suffer complications than those who don’t. Lupus Research Alliance Scientific Advisory Board members Dr. Virginia Pascual, Professor at Weill Cornell Medicine; and Dr. Jane Salmon, Collette Kean Research Professor  at Hospital for Special Surgery, and their colleagues asked if testing the blood, of pregnant […] READ MORE

Benlysta Approved for Children 5-Years and Up

April 26, 2019 We are very pleased to share news from GlaxoSmithKline (GSK) that intravenous Benlysta (belimumab) was approved by the U.S. Food and Drug Administration to treat children with lupus who are five years old or above. The approval was based on data from the ‘PLUTO’ study testing over one year the effectiveness and […] READ MORE

Test Available to Address Blood Clots in Lupus

April 24, 2019 The pharmaceutical company Exagen, Inc. announced study results showing that a component of their AVISE SLE Monitor test, the biomarker PC4d, can assess risk for thrombosis – a blood clot in the blood vessels. Study author Dr. Michelle Petri, Professor of Medicine at the Johns Hopkins University School of Medicine and Director […] READ MORE

Better Lupus Care Reducing Deaths from Lupus Nephritis, Study Shows

April 22, 2019 Results of a study published in Arthritis & Rheumatology shows that end-stage renal disease and mortality due to lupus nephritis is down from 2010-2014. Researchers at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School extended an analysis done in 1995 through 2006.  Using the national registry of patients […] READ MORE

Possible Reason Why Women at Greater Risk for Autoimmune Diseases

April 22, 2019 A study published in JCI Insight by researchers at University of Michigan Medical School suggests that the reason why women are more prone to autoimmune diseases than men may lie in excess levels of a protein VGLL3 in skin cells. Their study discovered that “too much VGLL3 in skin cells pushes the […] READ MORE

Learn and connect with our community!